Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · IEX Real-Time Price · USD
8.71
+0.31 (3.69%)
At close: Mar 28, 2024, 4:00 PM
7.68
-1.03 (-11.83%)
After-hours: Mar 28, 2024, 7:57 PM EDT

Pulse Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Cash & Equivalents
44.3761.1428.6112.466.951.13.392.093.61
Short-Term Investments
0008.0118.58.4834.6814.310
Cash & Cash Equivalents
44.3761.1428.6120.4825.459.5838.0716.43.61
Cash Growth
-27.44%113.67%39.75%-19.38%-57.37%56.51%132.20%354.66%-
Receivables
000.06000000
Inventory
005.82000000
Other Current Assets
0.961.012.131.861.010.780.410.270.39
Total Current Assets
45.3362.1536.6322.3426.460.3638.4816.664
Property, Plant & Equipment
8.7810.0211.2511.927.682.172.570.320.33
Goodwill and Intangibles
4.685.346.016.677.3488.679.3310
Other Long-Term Assets
0.370.370.370.370.490.10.100
Total Long-Term Assets
13.8315.7317.6218.9515.5110.2811.349.6510.33
Total Assets
59.1577.8854.2541.2941.9270.6449.8226.3114.33
Accounts Payable
1.841.572.91.721.961.270.780.270.26
Deferred Revenue
000.02000000
Current Debt
1.061.811.210.5400000
Other Current Liabilities
3.812.64.395.332.51.841.430.750.4
Total Current Liabilities
6.715.988.527.594.463.112.211.020.66
Long-Term Debt
8.0974.1410.0410.816.720000
Other Long-Term Liabilities
000001.21.6100
Total Long-Term Liabilities
8.0974.1410.0410.816.721.21.6100
Total Liabilities
14.7980.1318.5618.411.184.313.831.020.66
Total Debt
9.1475.9611.2511.366.720000
Debt Growth
-87.96%575.17%-0.93%69.01%-----
Retained Earnings
-336.92-294.71-236.2-172.54-122.69-75.72-38.17-12.61-3.09
Comprehensive Income
000-00-0-0.05-0.010
Shareholders' Equity
44.36-2.2535.6922.8930.7466.334625.313.67
Net Cash / Debt
35.22-14.8217.369.1218.6859.5838.0716.43.61
Net Cash / Debt Growth
--90.42%-51.18%-68.65%56.51%132.20%354.66%-
Net Cash Per Share
0.73-0.440.620.390.903.492.581.490.48
Working Capital
38.6256.1728.1114.7521.9457.2536.2715.653.34
Book Value Per Share
0.92-0.071.280.981.483.883.122.301.81
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).